These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 21220526)
1. In vitro activities of new 2-substituted quinolines against Leishmania donovani. Loiseau PM; Gupta S; Verma A; Srivastava S; Puri SK; Sliman F; Normand-Bayle M; Desmaele D Antimicrob Agents Chemother; 2011 Apr; 55(4):1777-80. PubMed ID: 21220526 [TBL] [Abstract][Full Text] [Related]
2. Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials. Vieira NC; Herrenknecht C; Vacus J; Fournet A; Bories C; Figadère B; Espindola LS; Loiseau PM Biomed Pharmacother; 2008 Dec; 62(10):684-9. PubMed ID: 18849137 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-leishmanial activity of 1-aryl-β-carboline derivatives against Leishmania donovani. Gohil VM; Brahmbhatt KG; Loiseau PM; Bhutani KK Bioorg Med Chem Lett; 2012 Jun; 22(12):3905-7. PubMed ID: 22608390 [TBL] [Abstract][Full Text] [Related]
4. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani. Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, ADME characterization and antileishmanial evaluation of novel substituted quinoline analogs. Gopinath VS; Rao M; Shivahare R; Vishwakarma P; Ghose S; Pradhan A; Hindupur R; Sarma KD; Gupta S; Puri SK; Launay D; Martin D Bioorg Med Chem Lett; 2014 May; 24(9):2046-52. PubMed ID: 24726804 [TBL] [Abstract][Full Text] [Related]
6. Discovery of a new antileishmanial hit in 8-nitroquinoline series. Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents. Gopinath VS; Pinjari J; Dere RT; Verma A; Vishwakarma P; Shivahare R; Moger M; Kumar Goud PS; Ramanathan V; Bose P; Rao MV; Gupta S; Puri SK; Launay D; Martin D Eur J Med Chem; 2013 Nov; 69():527-36. PubMed ID: 24095747 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of Triclisia patens and some bisbenzylisoquinoline alkaloids against Leishmania donovani and Trypanosoma brucei brucei. del Rayo Camacho M; Phillipson JD; Croft SL; Rock P; Marshall SJ; Schiff PL Phytother Res; 2002 Aug; 16(5):432-6. PubMed ID: 12203262 [TBL] [Abstract][Full Text] [Related]
12. Toxicity of betulin derivatives and in vitro effect on promastigotes and amastigotes of Leishmania infantum and L. donovani. Wert L; Alakurtti S; Corral MJ; Sánchez-Fortún S; Yli-Kauhaluoma J; Alunda JM J Antibiot (Tokyo); 2011 Jul; 64(7):475-81. PubMed ID: 21522160 [TBL] [Abstract][Full Text] [Related]
13. Abietane-Type Diterpenoid Amides with Highly Potent and Selective Activity against Leishmania donovani and Trypanosoma cruzi. Pirttimaa M; Nasereddin A; Kopelyanskiy D; Kaiser M; Yli-Kauhaluoma J; Oksman-Caldentey KM; Brun R; Jaffe CL; Moreira VM; Alakurtti S J Nat Prod; 2016 Feb; 79(2):362-8. PubMed ID: 26849852 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of chalcones as potential antileishmanial agents. Gupta S; Shivahare R; Korthikunta V; Singh R; Gupta S; Tadigoppula N Eur J Med Chem; 2014 Jun; 81():359-66. PubMed ID: 24858541 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel quinoline-based thiadiazole, evaluation of their antileishmanial potential and molecular docking studies. Almandil NB; Taha M; Rahim F; Wadood A; Imran S; Alqahtani MA; Bamarouf YA; Ibrahim M; Mosaddik A; Gollapalli M Bioorg Chem; 2019 Apr; 85():109-116. PubMed ID: 30605884 [TBL] [Abstract][Full Text] [Related]